Minimally Invasive Surgical Instrument Market to Surpass USD 21.1 Billion by 2026

Global minimally invasive surgical instrument market was valued at USD 12.8 billion in 2017, and is projected to exhibit a CAGR of 6.1 percent from 2018 – 2026. The minimally invasive surgical instrument market is expected to witness significant growth, owing to continuous technological advances in minimally invasive surgical instruments for ease of patients as well as surgeons during the surgical procedure. These instruments are equipped with high end cameras, imaging technology, robotics etc. For instance, Olympus Corporation and Sony in partnership launched an Ultra-HD surgical endoscopy system incorporating 4K technology 2015, in Japan and Europe, soon after launch of 4K recorder in 2016. The 4K camera head uses the Sony Exmor R CMOS image sensor to create high-sensitivity and low-noise images. It also features a one-touch auto-focus function that instantly focuses the image at the press of a button, which helps to shorten surgery times. The advanced laparoscopes, with employment of 4K cameras have eliminated the requirement for the surgeon to look into the binocular eyepiece, minimizing discomfort and stress. For cauterization, radiofrequency ablation systems and argon-enhanced electrosurgery allow efficient current delivery for improved outcomes and decreased operation time. Lasers are also used sometimes for ablating tissues or tumors.

Manufacturers are focusing on developing more innovative and convenient minimally invasive instruments, as these are used for less incisions, pain and fast recovery. For instance, staplers and endoscopic suturing devices such as the MicroCutter XCHANGE by Cardica, have allowed the performance of operations such as hemostatic bowel transection, closure of gastrostomy and sudden anastomosis with increasing reliability, and have provided better performance compared with manual stitching or clips.

Robotics offer unmatched solutions for minimally invasive surgeries. In robotic-assisted surgery, instruments are not moved through necessary controllers and software and not directly by the surgeon. For instance, the robotic surgical system da Vinci SP by Intuitive Surgical, which is the first and only console for teleoperated surgery received the Food and Drug Administration (FDA) approval. It has been adopted in hospitals and clinics worldwide for operations that range from urological to cardiac to abdominal surgery. There are many robotic minimally invasive surgical instruments in pipeline to be launched in 2019 and 2020. For instance, the companies’ joint-venture, Verb Surgical, is aiming to launch surgical robotic instruments in 2020, which can connect to the internet and learn from others. Medtronic PLC., also has a surgical robot due to launch in 2019. – Coherent Market Insights